alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit (b) to Form 10-QSB

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 8-K


                                 CURRENT REPORT
                       Pursuant to Section 13 and 15(d) of
                       the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported):                  June 29, 2001


                         Human Pheromone Sciences, Inc.
                         ------------------------------
             (Exact name of Registrant as specified in its charter)


     CALIFORNIA                       0-23544                  94 -3107202
     ----------                       -------                  -----------
(State or other jurisdiction        (Commission               (IRS Employer
      of incorporation)             File Number)           Identification No.)


84 West Santa Clara Street, Suite 720, San Jose, California        95113
-----------------------------------------------------------        -----
     (Address of principal executive offices)                    (Zip code)


Registrant's telephone number, including area code:             (408) 938-3030
                                                                --------------


        -----------------------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)



<PAGE>

Exhibit (b) to Form 10-QSB

                    INFORMATION TO BE INCLUDED IN THE REPORT


ITEM 4.       CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANTS

              (a)  As  reported  on Form 8-K  dated  June 15,  2001,  the  Audit
                   Committee of the Board of Directors of the Company authorized
                   the termination of BDO Seidman LLP as auditors of the Company
                   effective that day.

              (b)  As of June 29,  2001,  the  Company  engaged  Singer,  Lewak,
                   Greenbaum  &  Goldstein,  LLP  as the  Company's  independent
                   auditors to replace BDO Seidman, LLP.



                                    SIGNATURE

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                      HUMAN PHEROMONE SCIENCES, INC.



                                      By: /s/ William P. Horgan
                                      ------------------------------------------
                                      William P. Horgan, Chief Executive Officer
<PAGE>   1
 
                                                                    EXHIBIT 23.2
 
                        CONSENT OF INDEPENDENT AUDITORS
 
     We consent to the reference to our firm under the caption "Experts" in the
Registration Statement (Form S-4) and related Joint Proxy Statement/Prospectus
of Giant Industries, Inc. for the registration of 11,050,000 shares of its
common stock and to the incorporation by reference therein of our report dated
September 23, 1997, with respect to the consolidated financial statements of
Holly Corporation included in its Annual Report (Form 10-K) for the year ended
July 31, 1997, filed with the Securities and Exchange Commission.
 
                                                               ERNST & YOUNG LLP
                                                          /s/  ERNST & YOUNG LLP
 
May 1, 1998
Dallas, Texas
<Page>


INDEPENDENT AUDITORS' CONSENT


We consent to the use in this Post-Effective Amendment No. 2 to Registration
Statement No. 333-105261 of Hartford Life and Annuity Insurance Company
Separate Account Ten on Form N-4, of our report dated March 26, 2003 of
Hartford Life and Annuity Insurance Company relating to the statutory
financial statements as of and for the year ended December 31, 2002 and of
our report dated February 21, 2003 of Hartford Life and Annuity Insurance
Company Separate Account Ten relating to the financial statements as of and
for the year ended December 31, 2002, appearing in the Statement of
Additional Information, which is a part of such Registration Statement, and
to the reference to us under the headings "Experts" in such Statement of
Additional Information.

Deloitte & Touche LLP
Hartford, Connecticut
October 6, 2003
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE SM&A
CORPORATION UNAUDITED FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED MARCH 31,
1999.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                             835
<SECURITIES>                                         0
<RECEIVABLES>                                   29,162
<ALLOWANCES>                                       643
<INVENTORY>                                          0
<CURRENT-ASSETS>                                31,540
<PP&E>                                           3,424
<DEPRECIATION>                                     633
<TOTAL-ASSETS>                                  76,107
<CURRENT-LIABILITIES>                           11,220
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           164
<OTHER-SE>                                      57,092
<TOTAL-LIABILITY-AND-EQUITY>                    57,256
<SALES>                                         25,314
<TOTAL-REVENUES>                                25,314
<CGS>                                           14,737
<TOTAL-COSTS>                                   20,305
<OTHER-EXPENSES>                                  (39)
<LOSS-PROVISION>                                   643
<INTEREST-EXPENSE>                                  23
<INCOME-PRETAX>                                  5,048
<INCOME-TAX>                                     2,069
<INCOME-CONTINUING>                              2,979
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,979
<EPS-PRIMARY>                                     0.18
<EPS-DILUTED>                                     0.18
        

</TABLE>
I

106TH CONGRESS

1ST SESSION H. R. 1092

To amend the Internal Revenue Code of 1986 to more accurately codify

the depreciable life of semiconductor manufacturing equipment.

IN THE HOUSE OF REPRESENTATIVES

MARCH 11, 1999

Mrs. JOHNSON of Connecticut (for herself, Mr. MATSUI, Mr. CAMPBELL, Ms.

LOFGREN, Mr. COX, Mr. CUNNINGHAM, Mrs. TAUSCHER, Ms. ESHOO,

Mr. KUYKENDALL, Mr. SHOWS, Mrs. BONO, Mr. MCNULTY, Mr. SESSIONS, Mr. FROST, Mr. SAM JOHNSON of Texas, Mr. THOMPSON of California, Mr. KANJORSKI, Ms. DUNN, Mr. LEWIS of California, Mr.

RAMSTAD, Mr. HERGER, Mrs. NAPOLITANO, Mr. DOOLITTLE, Mr. PACKARD, Mr. BILBRAY, Mr. CONDIT, Mr. RADANOVICH, and Mr. POMBO) introduced the following bill; which was referred to the Committee on Ways

and Means

A BILL

To amend the Internal Revenue Code of 1986 to more accurately codify the depreciable life of semiconductor manufacturing equipment.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘Semiconductor Equip5 ment Investment Act of 1999’’.
2

•HR 1092 IH

1 SEC. 2. 3-YEAR DEPRECIABLE LIFE FOR SEMICONDUCTOR

2 MANUFACTURING EQUIPMENT.

3 (a) IN GENERAL.—Subparagraph (A) of section

4 168(e)(3) of the Internal Revenue Code of 1986 (relating

5 to classification of property) is amended by striking ‘‘and’’

6 at the end of clause (ii), by striking the period at the end

7 of clause (iii) and inserting ‘‘, and’’, and by adding at the

8 end the following new clause:

9 ‘‘(iv) any semiconductor manufacturing

10 equipment.’’

11 (b) CONFORMING AMENDMENTS.—

12 (1) Subparagraph (B) of section 168(e)(3) of

13 such Code is amended—

14 (A) by striking clause (ii),

15 (B) by redesignating clauses (iii) through

16 (vi) as clauses (ii) through (v), respectively, and

17 (C) by striking ‘‘clause (vi)(I)’’ in the last

18 sentence and inserting ‘‘clause (v)(I)’’.

19 (2) Subparagraph (B) of section 168(g)(3) of

20 such Code is amended by striking the items relating

21 to subparagraph (B)(ii) and subparagraph (B)(iii)

22 and inserting the following:

‘‘(A)(iv) ............................................................................... 3

‘‘(B)(ii) ............................................................................... 9.5’’.
3

•HR 1092 IH

1 (c) EFFECTIVE DATE.—The amendments made by

2 this section shall apply to equipment placed in service

3 after the date of the enactment of this Act.

Æ
1 

### Werner, Christopher

From: Szabo, Aaron <Aaron_L_Szabo@omb.eop.gov> Sent: Friday, March 11, 2016 10:22 AM To: Lorang, Phil; Werner, Christopher; Beaver, Melinda Cc: Szabo, Aaron Subject: Summary of Additional Interagency Comments under EO 12866 and 13563: EPA NPRM -- Protection of Visibility: Amendments to Requirem ents for State Plans (RIN 2060- AS55) Attachments: Summary of Additional Interagency Comments under EO 12866_E013563_RH NPRM....docx; Summary of Additional Interagency Com ments under EO12866_E013563 _RH NPRM....docx
Categories: Regional Haze

Attached please find the summary of additional inte ragency comments under EO 12866 and 13563 for the d raft proposed rule entitled, Protection of Visibility: Amendments to Requirement s for State Plans (RIN 2060-AS55). The interagency comments are based on the most recent i nformation provided to OMB for review.

Thank you and please let me know if you have any co mments or questions.

Aaron L. Szabo Policy Analyst Office of Information and Regulatory Affairs Office of Management and Budget 202-395-3621 Aaron_L_Szabo@omb.eop.gov
I

106TH CONGRESS

1ST SESSION H. R. 1094

To amend the Federal Reserve Act to broaden the range of discount window

loans which may be used as collateral for Federal reserve notes.

IN THE HOUSE OF REPRESENTATIVES

MARCH 11, 1999

Mr. LEACH (for himself, Mr. LAFALCE, Mr. BACHUS, and Ms. WATERS) introduced the following bill; which was referred to the Committee on

Banking and Financial Services

A BILL

To amend the Federal Reserve Act to broaden the range

of discount window loans which may be used as collateral

for Federal reserve notes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 That the 2d sentence of the 2d undesignated paragraph

4 of section 16 of the Federal Reserve Act (12 U.S.C. 412)

5 is amended by striking ‘‘acceptances acquired under sec6 tion 13 of this Act’’ and inserting ‘‘acceptances acquired

7 under section 10A, 10B, 13, or 13A of this Act’’.

Æ
No. 52131.

protests 129783-K, etc, (San Francisco).

#### Fung Chong Co. et al. *v.*United States,

*254Opinion by

Cline, J.

It was stipulated that the merchandise consists of kumquats similar in all material respects to those the subject of *United States*v. *Fung Chong Co.*(34 C. C. P. A. 40, C. A. D. 342). In accordance therewith the claim at 1 cent per pound under paragraph 743 was sustained.
Before the Second Division,

August 15, 1947

No. 51868.

#### Geo. S. Bush & Co., Inc. *v.*United States,

protests 110293-G, etc. (Seattle).

Opinion by

Tilson, J.

It was stipulated that the merchandise consists of imitation gut similar in all material respects to that the classification of which was involved in *Bush*v. *United States*(34 C. C. P. A. 17, C. A. D. 338). Upon the established facts and following the cited authority, the claim of the plaintiff was sustained.
**EXHIBIT 23.1**

**Consent of Independent Registered Public Accounting Firm**

We consent tothe incorporation by reference in the Registration Statements on Forms S-3 (Nos. 333-132330, 333-141964 and 333-171628) and Forms S-8 (Nos. 333-137782, 333-144061, 333-160256 and 333-171627) of Chelsea Therapeutics International, Ltd. and Subsidiaryand in the related Prospectuses of our reports dated March 2, 2011, with respect to the consolidated financial statements of Chelsea Therapeutics International, Ltd. and Subsidiary, and the effectiveness of internal control over financialreporting of Chelsea Therapeutics International, Ltd. and Subsidiary, included in this Annual Report (Form 10-K/A) for the year ended December 31, 2010. 

/s/    Ernst & Young LLP 

Raleigh, North Carolina 

April 7, 2011
Exhibit 32.1





CERTIFICATION








Each of the undersigned officers of
Cyalume Technologies Holdings, Inc. (the "Company") hereby certifies that,
to his knowledge, the Company's Amendment to theAnnual Report on
Form 10-K/A to which
this certification is attached (the "Report"), as filed with the Securities and
Exchange Commission on the date hereof, fully complies with the requirements of
Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of
1934, as amended (the "Exchange Act"), and that the information contained in the
Report fairly presents, in all material respects, the financial condition and
results of operations of the Company.




Date: April 16,
      2009
              
              /s/  DEREK
      DUNAWAYDerek
      Dunaway, Chief Executive Officer(the
      Principal Executive Officer)


Date: April 16,
      2009
                
                /s/  MICHAEL
      BIELONKOMichael
      Bielonko, Chief Financial Officer(the
      Principal Financial Officer)


This certification is being furnished
and not filed, and shall not be incorporated into any document for any purpose,
under the Securities Exchange Act of 1934 or the Securities
Act





S -
9
No. 63500.

protest 200680-K (New York).

#### Electrolux Corporation *v.*United States,

Opinion by

Ford, J.

In accordance with stipulation of counsel that the merchandise consists of electrical floor polishers similar in all material respects to those the subject of *United States*v. *Electrolux Corporation*(46 C.C.P.A. 143, C.A.D. 718), the claim of the plaintiff was sustained.
<TABLE> <S> <C>


<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JUN-30-1999
<PERIOD-START>                             JUL-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                       1,340,657
<SECURITIES>                                         0
<RECEIVABLES>                                3,814,037
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             7,008,526
<PP&E>                                       2,477,621
<DEPRECIATION>                                (108,374)
<TOTAL-ASSETS>                              10,009,690
<CURRENT-LIABILITIES>                       10,561,308
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        75,067
<OTHER-SE>                                    (626,685)
<TOTAL-LIABILITY-AND-EQUITY>                10,009,690
<SALES>                                     31,384,284
<TOTAL-REVENUES>                            31,384,284
<CGS>                                       26,828,754
<TOTAL-COSTS>                               26,828,754
<OTHER-EXPENSES>                             9,707,070
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             217,210
<INCOME-PRETAX>                             (5,338,825)
<INCOME-TAX>                                     9,601
<INCOME-CONTINUING>                         (1,815,931)
<DISCONTINUED>                              (3,532,495)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (5,348,426)
<EPS-PRIMARY>                                    (0.73)
<EPS-DILUTED>                                        0
        


</TABLE>
In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

* * * * * * * * * * * * * * * * * * * * *

KIMBERLY BOWMAN, *

* No. 13-807V

Petitioner, * Special Master Christian J. Moran

*

v. * Filed: June 17, 2014

*

SECRETARY OF HEALTH * Stipulation; influenza (“flu”)

AND HUMAN SERVICES, * vaccine; shoulder injury related to

* vaccine administration (“SIRVA”).

Respondent. *

* * * * * * * * * * * * * * * * * * * * *

Andrew D.Downing, Hennelly & Steadman, P.C., Phoenix, AZ, for Petitioner;

Gordon E. Shemin, United States Dep’t of Justice, Washington, DC, for 

Respondent.

UNPUBLISHED RULING FINDING ENTITLEMENT1

On October 17, 2013, Kimberly Bowman sought compensation for 

tendonitis in her left shoulder, resulting from the administration of the influenza 

(“flu”) vaccination on October 20, 2010. Ms. Bowman seeks compensation 

pursuant to the National Vaccine Injury Compensation Program, 42 U.S.C. § 

300aa-10 et seq. (2006). 

In the Rule 4 (c) report, respondent stated that Ms. Bowman’s claim is 

compensable under the Act. Respondent stated that the Division of Vaccine Injury 

Compensation, Department of Health and Human Services, has reviewed the facts 

of this case and have concluded that “petitioner’s alleged injury is consistent with a 

shoulder injury related to vaccine administration (“SIRVA”) and that it was caused 

in fact by the flu vaccine she received on October 20, 2010.” Resp’t’s Rep., filed 

June 17, 2014, at 3. Respondent further states that “based on the record as it now 

 

1 The E-Government Act of 2002, Pub. L. No. 107-347, 116 Stat. 2899, 2913 (Dec. 17, 

2002), requires that the Court post this decision on its website. Pursuant to Vaccine Rule 18(b), 

the parties have 14 days to file a motion proposing redaction of medical information or other 

information described in 42 U.S.C. § 300aa-12(d)(4). Any redactions ordered by the special 

master will appear in the document posted on the website. 
stands, petitioner has satisfied all legal prerequisites for compensation under the 

Act.” Id. at 4. 

Special masters may determine whether a petitioner is entitled to 

compensation based upon the record. A hearing is not required. 42 U.S.C. § 

300aa-13; Vaccine Rule 8(d). Based upon a review of the record as a whole, the 

undersigned finds that petitioner has established that she is entitled to 

compensation for her injuries. 

Accordingly, Ms. Bowman is entitled to compensation. A status 

conference REMAINS set for Wednesday, July 9, 2014 at 2:30 P.M. Eastern 

Time to discuss the process for quantifying the amount of damages to which Ms. 

Bowman is entitled.

Any questions may be directed to my law clerk, Mary Holmes, at (202) 357-

6353.

IT IS SO ORDERED. 

s/Christian J. Moran

Christian J. Moran

Special Master
# L_2022089EN.01001001.xml

| 17.3.2022 | EN | Official Journal of the European Union | L 89/10 |
| --- | --- | --- | --- |

17.3.2022

EN

Official Journal of the European Union

L 89/10

---

Corrigendum to Commission Implementing Regulation (EU) 2022/195 of 11 February 2022 amending and correcting Implementing Regulation (EU) 2020/683 as regards the information document, the vehicle approval certificates, the test result sheet and the certificates of conformity in paper format

(
  Official Journal of the European Union L 31 of 14 February 2022
  )

On page 36, point ‘(9) Part 2 (vehicle category N3) is corrected as follow:’, in point ‘(1) Point 7 is replaced by the following:’:

for:

| ‘“7. | Height: ... mm”’, |
| --- | --- |

‘“7.

Height: ... mm”’,

read:

| ‘“7. | Height: ... mm (179)”’. |
| --- | --- |

‘“7.

Height: ... mm (179)”’.

179

---
IN THE SUPREME COURT OF THE STATE OF DELAWARE

RICHARD B. CAREY and CAREY’S §

HOME CONSTRUCTION, LLC, § No. 407, 2015

§

Plaintiffs Below, §

 Appellants, § Court Below – Superior Court

§ of the State of Delaware

v. §

§ C.A. No. S11C-10-029

THE ESTATE OF DAVID L. §

MYERS and ARLENE MYERS, §

§

 Defendants Below, §

 Appellees. §

Submitted: January 20, 2016

Decided: January 28, 2016

Before STRINE, Chief Justice; VAUGHN, and SEITZ, Justices.

ORDER

This 28th day of January 2016, after careful consideration of the parties’ 

briefs and the record on appeal, we find it evident that the judgment of the Superior 

Court should be affirmed on the basis of and for the reasons assigned by the 

Superior Court in its decision dated July 1, 20151

.

NOW, THEREFORE, IT IS ORDERED that the judgment of the Superior 

Court is AFFIRMED.

BY THE COURT:

/s/ Collins J. Seitz, Jr.

Justice

 1 Carey v. Estate of Myers, 2015 WL 4087056 (Del. Super. July 1, 2015).
Exhibit 32b

Certification Pursuant to Section 1350 of Chapter 63 of Title 18of the United States Code

I, Morton A. Plawner, Chief Financial Officer of PSE&G Transition Funding II LLC, to the best of my knowledge, certify that (i) the Annual Report of PSE&G Transition Funding II LLC on Form 10-K for the year ended
December 31, 2006 (the "Periodic Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the information contained in the Periodic Report fairly presents, in all material respects, the
financial condition and results of operations of PSE&G Transition Funding II LLC.

| | /s/ | MORTONA. PLAWNER        | 
| | --- | ----------------------- | 
| |     | Morton A. Plawner      
| |     | Chief Financial Officer
| |     | March 14, 2007         

---
Table of Contents

Exhibit 13.1

Contax Participações S.A.Certification18 U.S.C Section 1350, as adopted pursuant to 
  Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of Title 18, United States Code), each of the undersigned officers of Contax Participações
S.A. (the Company), does hereby certify, to such officers knowledge, that:

The Annual Report on Form 20-F for the year ended December 31, 2008 of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the
Form 20-F fairly presents, in all material respects, the financial condition and results of operations of the Company.

|                    |        |                                | 
|------------------- | ------ | ------------------------------ | 
|Date: June 29, 2009 |        |                                | 
|                   
|                    |        | /s/ Francis James Leahy Meaney | 
|                    |        |                                | 
|                    | Name:  | Francis James Leahy Meaney     | 
|                    | Title: | Chief Executive Officer        | 
|Date: June 29, 2009 |        |                                | 
|                   
|                    |        | /s/ Michel Neves Sarkis        | 
|                    |        |                                | 
|                    | Name:  | Michel Neves Sarkis            | 
|                    | Title: | Chief Financial Officer        | 

---